Balsiger LM, Santos J, Serra J, Piessevaux H, et al. A Phase II, multicentric, randomized, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX(R) 600 mg tablets administered three or two times daily to patients with diarrhea-predominant irritable bowel syn Am J Gastroenterol 2024 Nov 26. doi: 10.14309/ajg.0000000000003236.
PMID: 39589118